Boleo Foundation (PL2 Sample Clauses

Boleo Foundation (PL2. 7) A foundation-type institution will be formed with MMB as the catalyst, but in the expectation that it will become a more general vehicle for philanthropic and practical programs developed in aid of the community. The specific form the foundation will take will depend on Mexican law and the experience of other similar institutions. Environmental and Social Action Plan Page 44 6 COMMUNITY AND EMPLOYEE HEALTH, SAFETY AND PROTECTION (PL3 CEHSP) El Boleo is a major mining and metallurgical industrial operation. Construction will engage a sizable crew that will develop civil and mechanical works with their associated hazards, as well as the assembling and testing of process equipment. It will involve operational hazards related to underground extractive operations, heavy machinery maneuvers, and chemicals handling. All this implies the need to manage the safety risks to all workers, employees and contractors involved in its different stages of development. Although a remote possibility, accidents or contingency situations at the site might affect the nearby community of Santa Xxxxxxx. Additionally, and as a major operation with significant material resources (such as heavy machinery), it has on obligation to assist the population in case of emergency situations that may derive from natural phenomena. MMB has pledged to make employee and community health and safety a guiding principle for all its actions. In particular, health and safety will be non–negotiable and a personal responsibility every MMB employee, contractor, and consultant. These principles are applied through development of a safety program based on the identification of hazards and the evaluation of risks with subsequent selection of behaviors and equipments to manage those hazards and risks followed by adequate training to properly employ them. The Community and Employee Health, Safety, and Protection Plan is the strategic framework for the application of these basic principles to both Worker Safety and Health and Community Safety and Health as they relate to Boleo activities.
AutoNDA by SimpleDocs
Boleo Foundation (PL2. 7) This program will be the vehicle for implementation of many of the community engagement programs discussed in the ESAP. The structure and function of the foundation will be elaborated once financing for the project is received.
Boleo Foundation (PL2. 7) This program will be developed during 2010. Funding for this program from Boleo will be $200,000.

Related to Boleo Foundation (PL2

  • Fifth Amended and Restated Limited Liability Company Operating Agreement Dated as of November 30, 2012

  • Certification of Limited Liability Company and Limited Partnership Interests Each interest in any limited liability company or limited partnership controlled by any Grantor and pledged hereunder shall be represented by a certificate, shall be a “security” within the meaning of Article 8 of the New York UCC and shall be governed by Article 8 of the New York UCC.

  • Asset Management a. Data Sensitivity - Transfer Agent acknowledges that it understands the sensitivity of Fund Data.

  • The Limited Liability Company 8 2.1 Formation; Effective Date of Agreement .................................... 8 2.2 Name ...................................................................... 8 2.3 Business Purpose .......................................................... 9 2.4 Powers .................................................................... 9 2.5 Duration .................................................................. 9 2.6 Registered Office and Registered Agent .................................... 9 2.7

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Technology Transfer Subject to the terms of the Development Supply Agreement, as soon as reasonably practicable, but in no event later than the fifth (5th) anniversary of the Effective Date, Alnylam shall initiate a technology transfer to MedCo, or to its Third Party manufacturer(s) of Licensed Product, selected by MedCo and reasonably acceptable to Alnylam, of Alnylam Know-How that is reasonably necessary or useful for the Manufacture of the Licensed Product, and shall make available its personnel on a reasonable basis to consult with MedCo or such Third Party manufacturer(s) with respect thereto, all at MedCo’s expense, including the Costs reasonably incurred by Alnylam in connection with such technology transfer activities. MedCo shall reimburse Alnylam such Costs incurred with respect to such Manufacturing technology transfer within [***] days after receipt of an invoice therefor. Alnylam and its Affiliates shall keep complete and accurate records in sufficient detail to enable the payments payable hereunder to be determined. Alnylam shall not be required to perform technology transfer to more than one Third Party manufacturer for each stage of the Licensed Product supply chain (i.e., Bulk Drug Substance, Bulk Drug Product and Finished Product). Promptly after MedCo’s written request, Alnylam shall use Commercially Reasonable Efforts to assign to MedCo any manufacturing agreement between Alnylam and a Third Party that is solely related to the manufacture of Licensed Products. Such assignment shall be subject to the terms and conditions of such agreement, including any required consents of such Third Party and MedCo’s written agreement to assume all the obligations of Alnylam under such agreement to be undertaken after such assignment, but Alnylam shall remain solely responsible for its obligations under such agreement arising prior to such assignment. Except as provided in the immediately preceding sentence, MedCo shall be solely responsible for contracting with such Third Party manufacturer (and any other Third Party manufacture to whom Alnylam has initiated technology transfer as set forth in this Section 5.3) for the supply of such Licensed Product and Alnylam shall have no obligations under such agreement between MedCo and such Third Party manufacturer. Alnylam shall use Commercially Reasonable Efforts to obtain any such consent in a form reasonably acceptable to MedCo.

  • Limited Liability Company Agreement The Member hereby states that except as otherwise provided by the Act or the Certificate of Formation, the Company shall be operated subject to the terms and conditions of this Agreement.

  • Certificate of Limited Liability Company Interest A Member’s limited liability company interest may be evidenced by a certificate of limited liability company interest executed by the Manager or an officer in such form as the Manager may approve; provided that such certificate of limited liability company interest shall not bear a legend that causes such limited liability company interest to constitute a security under Article 8 (including Section 8-103) of the Uniform Commercial Code as enacted and in effect in the State of Delaware, or the corresponding statute of any other applicable jurisdiction.

  • Investment Company; Public Utility Holding Company Neither the Company nor any Subsidiary is an "investment company" or a company "controlled" by an "investment company" within the meaning of the Investment Company Act of 1940, as amended, or a "public utility holding company" within the meaning of the Public Utility Holding Company Act of 1935, as amended.

  • Partnership and Limited Liability Company Interests Except as previously disclosed to the Administrative Agent, none of the Collateral consisting of an interest in a partnership or a limited liability company (i) is dealt in or traded on a securities exchange or in a securities market, (ii) by its terms expressly provides that it is a Security governed by Article 8 of the UCC, (iii) is an Investment Company Security, (iv) is held in a Securities Account or (v) constitutes a Security or a Financial Asset.

Time is Money Join Law Insider Premium to draft better contracts faster.